Sanofi Strikes Deal To Develop Respiratory Health App
Sanofi Consumer Healthcare is working with digital health firm ResApp to develop a mobile application which consumers can use to diagnose and manage respiratory illnesses. Such a tool has the potential to support novel Rx-to-OTC switch applications in future.
You may also be interested in...
Australia's ResApp has terminated a deal with RB to bring to market a smartphone app to identify different respiratory conditions. Previously, Sanofi and ResApp failed to agree a deal for the technology.
Reckitt will work with former Sanofi partner ResApp to develop a consumer app which can diagnose common respiratory issues. The partnership represents RB's latest move into the digital space for its Health business.
Sanofi Consumer Healthcare has teamed up with digital health player Cara Care to offer an innovative treatment for IBS which goes beyond the pill and helps sufferers access personalized support for their illness.